NYSE ARCA | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.67% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 4.61% |
| GMAB | Genmab AS | Healthcare | Biotechnology | 4.54% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.35% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.24% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology | 4.07% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 4.00% |
| ONC | BeiGene, Ltd. | Healthcare | Biotechnology | 3.86% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.81% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.79% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.79% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.74% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.68% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 3.65% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.58% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 3.55% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 3.44% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 3.41% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.38% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.37% |